Pee test could spot cancer changes without needles
NCT ID NCT07468838
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study explores whether analyzing tumor DNA in urine can be a simple, non-invasive way to monitor prostate and bladder cancer. Researchers will collect urine samples from 25 patients at different treatment stages to see if the test can detect cancer mutations and track changes over time. No experimental treatment is involved—the goal is to validate the method as a potential alternative to repeated biopsies.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a simple urine test to monitor cancer without invasive biopsies, helping doctors adjust treatment more easily.
- What could go wrong
- This is a very small, early feasibility study with only 25 participants. It may not prove the test is reliable enough for routine use, and technical challenges could arise.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new tracer light up hidden prostate cancer?
- Could deep breaths before surgery ward off Post-Op confusion?
- Can a Bag-Like device pull bladder tumors out whole?
- A second look: MRI screening may spot hidden prostate cancers
- Can Pre-Surgery chemotherapy outsmart aggressive bladder cancer?
- Can precision protons spare the bowel in prostate cancer?